Literature DB >> 24426958

Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.

Nash H Naam1.   

Abstract

BACKGROUND: This study was designed to provide comparative information on the safety and efficacy of injection with collagenase clostridium histolyticum (CCH) and fasciectomy for patients with Dupuytren's contracture (DC).
METHODS: A single-center, retrospective, observational, longitudinal chart review was conducted of 25 patients treated with CCH injections and 21 patients undergoing fasciectomy. Patients were assessed at 1 week, monthly for 3 months and then yearly for a minimum of 2 years after treatment for changes in contracture and range of motion, time to return to work/normal activities, patient satisfaction, and Disabilities of Arm, Shoulder and Hand (DASH) score.
RESULTS: Post-procedure follow-up averaged 32 months for the injection group compared with 39 months for fasciectomy group. For the CCH group, the mean postinjection contracture was 3.6° for the metacarpophalangeal and 17.5° for the proximal interphalangeal joints compared with 3.7° and 8.1° in the fasciectomy group, respectively. Patients treated with injections returned to normal activities after a mean of 1.9 days compared with 37.4 days for fasciectomy patients (p < 0.0001). DASH scores for 13 CCH and 15 fasciectomy patients were obtained. The mean DASH score was significantly lower in the injection group in the first 3 months (p < 0.01). At the 2-year follow-up visit, patients were satisfied with their outcomes following either treatment (92 % and 96 % of CCH and fasciectomy patients, respectively).
CONCLUSION: CCH injections are safe and effective and may be a viable alternative to fasciectomy for treating DC. It also allows earlier return to work and daily activities.

Entities:  

Keywords:  Collagenase; Dupuytren’s contracture; Fasciectomy

Year:  2013        PMID: 24426958      PMCID: PMC3840748          DOI: 10.1007/s11552-013-9540-7

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  19 in total

Review 1.  Collagenase clostridium histolyticum for Dupuytren's contracture.

Authors:  Shaunak S Desai; Vincent R Hentz
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

2.  Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients.

Authors:  J Henk Coert; Juan P Barret Nérin; Marcel F Meek
Journal:  Ann Plast Surg       Date:  2006-07       Impact factor: 1.539

Review 3.  Dupuytren disease: Anatomy, pathology, presentation, and treatment.

Authors:  Ghazi M Rayan
Journal:  J Bone Joint Surg Am       Date:  2007-01       Impact factor: 5.284

4.  Postoperative hand therapy in Dupuytren's disease.

Authors:  Hester Herweijer; Pieter U Dijkstra; Jean-Philippe A Nicolai; Corry K Van der Sluis
Journal:  Disabil Rehabil       Date:  2007-11-30       Impact factor: 3.033

Review 5.  The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies.

Authors:  S M Crean; R A Gerber; M P Hellio Le Graverand; D M Boyd; J C Cappelleri
Journal:  J Hand Surg Eur Vol       Date:  2011-03-07

6.  Current surgical treatment of Dupuytren's disease.

Authors:  G R Wilson
Journal:  Br J Clin Pract       Date:  1997-03

7.  Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.

Authors:  David Gilpin; Stephen Coleman; Stephen Hall; Anthony Houston; Jeff Karrasch; Nigel Jones
Journal:  J Hand Surg Am       Date:  2010-12       Impact factor: 2.230

8.  Partial fasciectomy for Dupuytren's contractures.

Authors:  Andreas F Mavrogenis; Sarantis G Spyridonos; Ioannis A Ignatiadis; Dimitrios Antonopoulos; Panayiotis J Papagelopoulos
Journal:  J Surg Orthop Adv       Date:  2009

9.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

10.  Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts.

Authors:  Christopher Bainbridge; Lars B Dahlin; Piotr P Szczypa; Joseph C Cappelleri; Daniel Guérin; Robert A Gerber
Journal:  Eur Orthop Traumatol       Date:  2012-03-06
View more
  10 in total

1.  Dupuytren Disease Management Trends: A Survey of Hand Surgeons.

Authors:  Logan Carr; Brett Michelotti; Morgan Brgoch; Randy Hauck; John Ingraham
Journal:  Hand (N Y)       Date:  2018-07-25

2.  Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.

Authors:  Raghuveer C Muppavarapu; Michael J Waters; Matthew I Leibman; Mark R Belsky; David E Ruchelsman
Journal:  Hand (N Y)       Date:  2015-06

Review 3.  Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.

Authors:  Francesco Smeraglia; Angelo Del Buono; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

4.  Treatment of Dupuytren's Contracture With Collagenase: A Systematic Review.

Authors:  Alexis B Sandler; John P Scanaliato; Thomas Dennis; Gilberto A Gonzalez Trevizo; Sorana Raiciulescu; Leon Nesti; John C Dunn
Journal:  Hand (N Y)       Date:  2021-01-21

Review 5.  Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days.

Authors:  Scott M Schulze; James P Tursi
Journal:  Hand (N Y)       Date:  2014-12

6.  DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.

Authors:  Mikko P Räisänen; Teemu Karjalainen; Harry Göransson; Aleksi Reito; Hannu Kautiainen; Antti Malmivaara; Olli V Leppänen
Journal:  BMJ Open       Date:  2018-03-28       Impact factor: 2.692

7.  Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.

Authors:  Suresh K Nayar; Dennis Pfisterer; John V Ingari
Journal:  Clin Orthop Surg       Date:  2019-08-12

8.  Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.

Authors:  Alfred P Yoon; Robert L Kane; David W Hutton; Kevin C Chung
Journal:  JAMA Netw Open       Date:  2020-10-01

9.  Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren's Deformity Correction.

Authors:  Sarang Kasture; Raj Sakamuri
Journal:  Cureus       Date:  2021-11-27

Review 10.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.